Fogaça, Manoela V.

Cannabidiol, neuroprotection and neuropsychiatric disorders

Campos, A. C., Fogaça, M. V., Sonego, A. B., & Guimarães, F. S. (2016) · Pharmacological Research

Cannabis and Cannabinoid ResearchNeuroscience and Neuropharmacology Research

Cited by 446

Cortical GABAergic Dysfunction in Stress and Depression: New Insights for Therapeutic Interventions

Fogaça, M. V., & Duman, R. S. (2019) · Frontiers in Cellular Neuroscience

Treatment of Major DepressionNeuroscience and Neuropharmacology Research

Cited by 396

Role of BDNF in the Pathophysiology and Treatment of Depression: Activity-Dependent Effects Distinguish Rapid-Acting Antidepressants

Duman, R. S., Deyama, S., & Fogaça, M. V. (2021) · European Journal of Neuroscience

Treatment of Major DepressionNerve injury and regeneration

Cited by 321

The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system

Campos, A. C., Ortega, Z., Palazuelos, J., Fogaça, M. V., Aguiar, D. C., Díaz-Alonso, J., Ortega-Gutiérrez, S., Vázquez-Villa, H., Moreira, F. A., Guzmán, M., et al. (2013) · International Journal of Neuropsychopharmacology

Cannabis and Cannabinoid ResearchMedicinal Plant Extracts Effects

Cited by 313

Plastic and neuroprotective mechanisms involved in the therapeutic effects of cannabidiol in psychiatric disorders

Campos, A. C., Fogaça, M. V., Scarante, F. F., Joca, S. R. L., Sales, A. J., Gomes, F. V., Sonego, A. B., Rodrigues, N. S., Galve-Roperh, I., & Guimarães, F. S. (2017) · Frontiers in Pharmacology

Cannabis and Cannabinoid ResearchPsychedelics and Drug Studies

Cited by 175

Effects of intra-prelimbic prefrontal cortex injection of cannabidiol on anxiety-like behavior: involvement of 5HT1A receptors and previous stressful experience

Fogaça, M. V., Reis, F. M. C. V., Campos, A. C., & Guimarães, F. S. (2014) · European Neuropsychopharmacology

Cannabis and Cannabinoid ResearchMedicinal Plant Extracts Effects

Cited by 153

Inhibition of GABA interneurons in the mPFC is sufficient and necessary for rapid antidepressant responses

Fogaça, M. V., Wu, M., Li, C., Li, X.-Y., Picciotto, M. R., & Duman, R. S. (2021) · Molecular Psychiatry

Treatment of Major DepressionNeuroscience and Neuropharmacology Research

Cited by 129

BDNF Release and Signaling Are Required for the Antidepressant Actions of GLYX-13

Kato, T., Fogaça, M. V., Deyama, S., Li, X.-Y., Fukumoto, K., & Duman, R. S. (2018) · Molecular Psychiatry

Treatment of Major DepressionNeuroscience and Neuropharmacology Research

Cited by 88

N-Methyl-D-aspartate receptor antagonist d-methadone produces rapid, mTORC1-dependent antidepressant effects

Fogaça, M. V., Fukumoto, K., Franklin, T., Liu, R.-J., Duman, C. H., Vitolo, O. V., & Duman, R. S. (2019) · Neuropsychopharmacology

Treatment of Major DepressionNeuroscience and Neuropharmacology Research

Cited by 82

Effects of intra-infralimbic prefrontal cortex injections of cannabidiol in the modulation of emotional behaviors in rats: Contribution of 5HT1A receptors and stressful experiences

Marinho, A. L. Z., Vila-Verde, C., Fogaça, M. V., & Guimarães, F. S. (2015) · Behavioural Brain Research

Cannabis and Cannabinoid ResearchNeurotransmitter Receptor Influence on Behavior

Cited by 68

Modulation of defensive behavior by transient receptor potential vanilloid type-1 (TRPV1) channels

Aguiar, D. C., Moreira, F. A., Terzian, A. L., Fogaça, M. V., Lisboa, S. F., Wotjak, C. T., & Guimaraes, F. S. (2014) · Neuroscience & Biobehavioral Reviews

Ion Channels and ReceptorsCannabis and Cannabinoid Research

Cited by 57